Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

NCT06890078 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2026-04-23

No results posted yet for this study

Summary

Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients

Conditions

  • Pneumocystis
  • Immunocompromised Patients

Interventions

OTHER

Biological sampling

Mouthwash, nasopharyngeal swab, blood sampling

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-08
Primary Completion
2027-07-08
Completion
2027-07-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06890078 on ClinicalTrials.gov